IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,216 | +10.6% | 600 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $24,618 | +14.8% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $21,444 | -5.4% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $22,662 | -16.1% | 600 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $27,000 | +22.7% | 600 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $22,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $22,000 | +22.2% | 600 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $18,000 | -10.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $20,000 | -16.7% | 600 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $24,000 | -11.1% | 600 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $27,000 | -20.6% | 600 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $34,000 | +21.4% | 600 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $28,000 | -20.0% | 600 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $35,000 | +25.0% | 600 | 0.0% | 0.01% | +9.1% |
| Q1 2020 | $28,000 | -22.2% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $36,000 | -25.0% | 600 | -25.0% | 0.01% | -31.2% |
| Q3 2019 | $48,000 | -5.9% | 800 | 0.0% | 0.02% | -11.1% |
| Q2 2019 | $51,000 | -21.5% | 800 | 0.0% | 0.02% | -25.0% |
| Q1 2019 | $65,000 | +51.2% | 800 | 0.0% | 0.02% | +41.2% |
| Q4 2018 | $43,000 | – | 800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |